» Articles » PMID: 21997203

Proteomic Analysis of Urine in Medication-overuse Headache Patients: Possible Relation with Renal Damages

Overview
Journal J Headache Pain
Publisher Biomed Central
Date 2011 Oct 15
PMID 21997203
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Medication-overuse headache (MOH) is a chronic disorder associated with overuse of analgesic drugs, triptans, non-steroidal anti-inflammatory drugs (NSAIDs) or other acute headache compounds. Various epidemiologic investigations proved that different drug types could cause nephrotoxicity, particularly in chronic patients. The aim of the present work was to analyze, by a proteomic approach, the urinary protein profiles of MOH patients focusing on daily use of NSAIDs, mixtures and triptans that could reasonably be related to potential renal damage. We selected 43 MOH patients overusing triptans (n = 18), NSAIDs (n = 11), and mixtures (n = 14), for 2-30 years with a mean daily analgesic intake of 1.5 ± 0.9 doses, and a control group composed of 16 healthy volunteers. Urine proteins were analyzed by mono-dimensional gel electrophoresis and identified by mass spectrometry analysis. Comparing the proteomic profiles of patients and controls, we found a significantly different protein expression, especially in the NSAIDs group, in which seven proteins resulted over-secreted from kidney (OR = 49, 95% CI 2.53-948.67 vs. controls; OR = 11.6, 95% CI 0.92-147.57 vs. triptans and mixtures groups). Six of these proteins (uromodulin, α-1-microglobulin, zinc-α-2-glycoprotein, cystatin C, Ig-kappa-chain, and inter-α-trypsin heavy chain H4) were strongly correlated with various forms of kidney disorders. Otherwise, in mixtures and in triptans abusers, only three proteins were potentially associated to pathological conditions (OR = 4.2, 95% CI 0.33-53.12, vs. controls). In conclusion, this preliminary proteomic study allowed us to define the urinary protein pattern of MOH patients that is related to the abused drug. According with the obtained results, we believe that the risk of nephrotoxicity should be considered particularly in MOH patients who abuse of NSAIDs.

Citing Articles

Recent progress in mass spectrometry-based urinary proteomics.

Joshi N, Garapati K, Ghose V, Kandasamy R, Pandey A Clin Proteomics. 2024; 21(1):14.

PMID: 38389064 PMC: 10885485. DOI: 10.1186/s12014-024-09462-z.


Proteomics Disclose the Potential of Gingival Crevicular Fluid (GCF) as a Source of Biomarkers for Severe Periodontitis.

Bellei E, Bertoldi C, Monari E, Bergamini S Materials (Basel). 2022; 15(6).

PMID: 35329612 PMC: 8950923. DOI: 10.3390/ma15062161.


Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache.

Shnayder N, Sharavii V, Petrova M, Moskaleva P, Pozhilenkova E, Kaskaeva D Int J Mol Sci. 2021; 22(16).

PMID: 34445731 PMC: 8396559. DOI: 10.3390/ijms22169024.


Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine.

Bellei E, Bergamini S, Rustichelli C, Monari E, Dal Porto M, Fiorini A J Clin Med. 2021; 10(9).

PMID: 33923220 PMC: 8123166. DOI: 10.3390/jcm10091854.


Identification of Novel Biomarkers for Predicting Kidney Injury Due to Drugs Using "Omic" Strategies.

Awdishu L, Atilano-Roque A, Tuey S, Joy M Pharmgenomics Pers Med. 2020; 13:687-705.

PMID: 33293850 PMC: 7719321. DOI: 10.2147/PGPM.S239471.


References
1.
Romero M, Zanaro N, Gonzalez L, Trigo P, Imventarza O, Nesse A . Tamm-Horsfall protein excretion to predict the onset of renal insufficiency. Clin Biochem. 2002; 35(1):65-8. DOI: 10.1016/s0009-9120(02)00274-6. View

2.
Mischak H, Espandiari P, Sadrieh N, Hanig J . Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity using CE coupled with MS as a potential model for detection of drug-induced adverse effects. Proteomics Clin Appl. 2010; 3(9):1062-71. DOI: 10.1002/prca.200900030. View

3.
Bellei E, Bergamini S, Monari E, Fantoni L, Cuoghi A, Ozben T . High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids. 2010; 40(1):145-56. DOI: 10.1007/s00726-010-0628-x. View

4.
Hagen K, Albretsen C, Vilming S, Salvesen R, Gronning M, Helde G . A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J Headache Pain. 2011; 12(3):315-22. PMC: 3094644. DOI: 10.1007/s10194-010-0285-1. View

5.
Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands J . Urine in clinical proteomics. Mol Cell Proteomics. 2008; 7(10):1850-62. DOI: 10.1074/mcp.R800001-MCP200. View